Figure_2.tif (3.05 MB)
Clinical features related to GM3 in patients with RA or OA. A.
figure
posted on 2013-02-20, 03:07 authored by Yukinori Tsukuda, Norimasa Iwasaki, Naoki Seito, Masashi Kanayama, Naoki Fujitani, Yasuro Shinohara, Yasuhiko Kasahara, Tomohiro Onodera, Koji Suzuki, Tsuyoshi Asano, Akio Minami, Tadashi YamashitaHistology of RA and OA patients. Hematoxylin and eosin (HE) staining. Scale bars = 200 µm. B. Quantification of total GSL glycans in human synovium (n = 5 per group). C. Absolute and relative amounts of GM3 glycans in human synovium (n = 5 per group). D. Quantification of GM3S mRNA in synovium and PBMCs in RA and OA patients (n = 5 per group). Data shown are mean ± SEM. *P<0.05, compared to OA patients.